시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 만성 폐쇄성 폐질환(COPD) 및 천식 기기 시장 보고서(2025년)
Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report 2025
상품코드 : 1703124
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,344,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,170,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,996,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

만성 폐쇄성 폐질환(COPD) 및 천식 장치 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 6.1%로 605억 3,000만 달러에 달할 것으로 예측됩니다. 예측 기간의 성장은 호흡기 질환 발생률 증가, 담배 흡연율 증가, 환경 오염 수준 증가 및 호흡 문제, 호흡기 질환 유병률 증가, 의료비 지출 증가, 약물 전달 장치의 휴대성 증가 등에 기인합니다. 예측 기간의 주요 동향으로는 기술 발전, 스마트 기술 통합, 개인 맞춤형 의료, 생물학적 제제 채택, 웨어러블 호흡기 모니터 등이 있습니다.

호흡기 질환의 유병률 증가는 만성 폐쇄성 폐질환(COPD) 및 천식 장치 시장의 성장을 가속할 것으로 예측됩니다. 호흡기 질환에는 천식, COPD, 폐렴, 폐암 등 폐와 호흡기에 영향을 미치는 다양한 질환이 포함되며, 호흡과 호흡기 기능 전반에 영향을 미칩니다. 이러한 질환의 유병률 증가는 대기 오염의 심화, 알레르겐 및 병원균에 영향을 미치는 기후 변화, 호흡기 건강을 해치는 흡연과 같은 생활습관 선택과 같은 요인과 관련이 있으며, COPD 및 천식용으로 설계된 장치는 이러한 질환을 효과적으로 관리하고 치료하는 데 필수적입니다. 호흡기 건강을 개선하고 전반적인 웰빙을 향상시키는 데 도움을 주고 있습니다. 예를 들어, 세계보건기구(WHO)가 2023년 3월에 보고한 바에 따르면, COPD는 전 세계 사망원인 3위이며, 약 323만 명의 사망자 중 약 90%가 중저소득국가(LMICs)의 70세 미만에서 발생합니다. 이러한 호흡기 질환의 유병률 증가가 COPD 및 천식 기기 시장의 성장을 가속하고 있습니다.

COPD 및 천식 치료 기기 시장의 주요 기업들은 원격 모니터링 및 개인 맞춤형 치료를 위한 디지털 헬스 기능을 통합한 흡입 장치와 같은 혁신적인 기술 개발에 주력하고 있습니다. 흡입 장치는 흡입을 통해 폐에 직접 약물을 전달하는 데 사용됩니다. 예를 들어, 2022년 5월 인도 제약회사 Alkem Laboratories는 천식 및 COPD 환자의 삶을 개선하기 위해 설계된 건식 분말 흡입기(DPI)인 Innohaler를 출시했습니다. 정확한 약물 전달을 통해 투여량의 정확성을 높이고 낭비를 최소화합니다. 인체공학적 디자인으로 모든 연령대의 환자에게 적합한 사용하기 쉬운 인터페이스를 갖추고 있습니다. 또한, 컴팩트하고 휴대가 간편한 디자인으로 이동 중에도 편리하게 사용할 수 있어 치료 계획을 준수할 수 있도록 도와줍니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Devices for chronic obstructive pulmonary disease (COPD) and asthma are medical tools designed to manage and treat breathing and respiratory issues. These devices assist patients in breathing more efficiently, controlling symptoms, and enhancing their overall quality of life.

Key types of these devices include metered dose inhalers, dry powder inhalers, soft mist inhalers, jet nebulizers, ultrasonic nebulizers, and others. Metered Dose Inhalers are portable devices that administer medication in a precise spray or mist, commonly used for conditions such as COPD and asthma by delivering the medication directly into the lungs. They are small and easy to carry, making them suitable for everyday use. These devices are utilized in various settings such as hospitals, clinics, home care, and research facilities, and cater to different age groups including pediatric, adult, and geriatric patients.

The chronic obstructive pulmonary disease (COPD) and asthma devices market research report is one of a series of new reports from The Business Research Company that provides chronic obstructive pulmonary disease (COPD) and asthma devices market statistics, including chronic obstructive pulmonary disease (COPD) and asthma devices industry global market size, regional shares, competitors with an chronic obstructive pulmonary disease (COPD) and asthma devices market share, detailed chronic obstructive pulmonary disease (COPD) and asthma devices market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic obstructive pulmonary disease (COPD) and asthma devices industry. This chronic obstructive pulmonary disease (COPD) and asthma devices research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic obstructive pulmonary disease (COPD) and asthma devices market size has grown strongly in recent years. It will grow from $44.95 billion in 2024 to $47.83 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to growth in the elderly population, increasing incidence of allergies, increasing government initiatives, rise in clinical research and trials, and rise in urbanization.

The chronic obstructive pulmonary disease (COPD) and asthma devices market size is expected to see strong growth in the next few years. It will grow to $60.53 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising occurrences of respiratory diseases, rising smoking of cigarettes, rising environmental pollution levels and breathing problems, growing prevalence of respiratory diseases, growing healthcare expenditure, and rising portability of drug delivery devices. Major trends in the forecast period include technological advancements, integration of smart technology, personalized medicine, adoption of biologics, and wearable respiratory monitors.

The increasing incidence of respiratory diseases is anticipated to drive the expansion of the chronic obstructive pulmonary disease (COPD) and asthma devices market. Respiratory diseases include various conditions that affect the lungs and respiratory system, such as asthma, COPD, pneumonia, and lung cancer, which impact breathing and overall respiratory function. The rising prevalence of these diseases is linked to factors such as escalating air pollution, climate changes that influence allergens and pathogens, and lifestyle choices such as smoking that impair respiratory health. Devices designed for COPD and asthma are essential for effective management and treatment of these conditions, helping patients achieve better respiratory health and improved overall well-being. For example, as reported by the World Health Organization (WHO) in March 2023, COPD was the third leading cause of death worldwide, accounting for about 3.23 million deaths, with nearly 90% of these fatalities occurring in low- and middle-income countries (LMICs) among individuals under 70 years old. This rising prevalence of respiratory diseases is fueling growth in the COPD and asthma devices market.

Leading companies in the COPD and asthma devices market are concentrating on creating innovative technologies, such as inhalation devices with integrated digital health features for remote monitoring and personalized treatment. Inhalation devices are used to deliver medication directly to the lungs through inhalation. For instance, in May 2022, Alkem Laboratories, an Indian pharmaceutical company, launched the Innohaler, a dry powder inhaler (DPI) designed to improve the lives of people with asthma and COPD. The Innohaler features advanced breath-actuated technology for accurate medication delivery with each inhalation, enhancing dosage precision and minimizing waste. Its ergonomic design makes it easy to use, with a user-friendly interface suitable for patients of all ages. Additionally, its compact and portable design increases convenience for use on the go, supporting better adherence to treatment regimens.

In March 2022, Philip Morris International Inc., a US-based tobacco company, acquired Vectura Group plc. for an undisclosed amount. This acquisition is aimed at utilizing Vectura's expertise in inhalation technology to advance the development of reduced-risk products (RRPs) and other non-combustible alternatives. Vectura Group plc, a UK-based pharmaceutical company, specializes in inhaled medicines and inhaler devices for treating respiratory diseases such as asthma and COPD.

Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, 3M Health Care, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Baxter International Inc., Omron Corporation, Smiths Medical Inc., Recipharm AB, Cipla Ltd., Teleflex Incorporated, Chiesi Farmaceutici SpA, Lincre Holdings Inc., Sunovion Pharmaceuticals Inc., Verona Pharma plc, Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd.

North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2024. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic obstructive pulmonary disease (COPD) and asthma devices market consists of sales of spacer devices, peak flow meters, oxygen therapy equipment, pulse oximeters, and airway clearance devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic obstructive pulmonary disease (copd) and asthma devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for chronic obstructive pulmonary disease (copd) and asthma devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic obstructive pulmonary disease (copd) and asthma devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Characteristics

3. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Trends And Strategies

4. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Growth Analysis And Strategic Analysis Framework

6. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Segmentation

7. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Regional And Country Analysis

8. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

9. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

10. India Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

11. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

12. Australia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

13. Indonesia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

14. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

15. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

16. UK Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

17. Germany Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

18. France Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

19. Italy Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

20. Spain Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

21. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

22. Russia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

23. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

24. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

25. Canada Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

26. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

27. Brazil Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

28. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

29. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

30. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Landscape And Company Profiles

31. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Other Major And Innovative Companies

32. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

34. Recent Developments In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

35. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기